Nova Anchora
San Francisco · Founded 2021
About Nova Anchora
Nova Anchora, a biopharmaceutical startup, is developing a corrected protein therapy for DEB, a severe uncommon skin disease.
Company Facts
- Founded: 2021
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Apr 2025)
- Website: novaanchora.com
Social Profiles
Canonical: https://fsome.com/organization/nova-anchora-8392680 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.